News_Details

PHEXCOM

Solution BY Communication

>>Back

AstraZeneca bets up to $443M on Omthera lipid drug

Publisher：
Publication：2013/5/28

Pipeline-starved AstraZeneca ($AZN) snapped up Omthera ($OMTH) in a deal worth up to $443 million, on hopes for the company's omega-3 cardio drug Epanova.

Excipients

oleaginous vehicle
flavoring agent
viscosity-increasing agent
suspending agent
disintegrant
thickener
solvent
alkalizing agent
chelating agent
emulsifying agent
buffer
adhesive
coating agent
sweetening agent
film-former
gelling agent
solublizing agent
diluent
preservative
carrier